Alison Comber

Key Consultants

Alison has significant commercial, project management, and operational experience across a number of disciplines within the pharmaceutical and biotechnology sector.

Sector and Service Expertise

Alison has extensive experience in the Pharmaceutical and Biotechnology sectors, as well as Corporate Finance. She works with Skarbek’s clients on Project Management, Transformational Change and Mergers & Acquisitions.

Strengths and Career Achievements

Alison spent 5 years broadening her experience as a Healthcare and Life Sciences sector specialist in KPMG Corporate Finance, working with UK and European M&A and Private Equity teams. Prior to that she spent 16 years in a variety of roles in regulatory affairs, leading clinical drug development and drug development outsourcing in both the Pharmaceutical Industry and a service provider.

Alison’s consulting projects have been varied, including participating in an organisational review for a major company dividing assets into two new legal entities, and working on post acquisition integration. She has completed a number of consulting projects and interim management roles in pharmaceutical and biotech companies, leading teams working to regulatory deadlines.

Alison has an Applied Biology degree from Brunel University and an MBA from the Imperial College Management School.

Discover other key Skarbek people

Kasia Luther

Experienced marketeer with specialism in product development and multinational project management

Christi Novomesky

A highly experienced associate with more than 22 years of project management, innovation and operational experience.

Major General Graham Binns CBE, DSO, MC

Accomplished senior leader responsible for leadership development in the UK military, coach and advisor

Lisa Koh

Lisa is a supply chain professional, project manager and senior analyst

Thank you for the leadership training, it was really superb and we have already started to put it into action The talks were truly inspirational and we have discussed them many times already as we look for the key messages.
Global Innovation VP
FTSE 100